Financials
- Market Capitalization 151.55 M
- Employee 14
- Founded 2017
- CEO N/A
- Website www.equilliumbio.com
- Headquarter Delaware, United States
- FIGI BBG00LSL8C10
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-35.56
Rapporto prezzo/fatturato
-3 628.01
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3744 | NRXP NRX Pharmaceuticals, Inc. - Common Stock | 3.55 USD | -1.93% | -0.28% | +12.34% | +99.44% | 153.70 M USD | ||
| 3748 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.14 USD | -1.72% | -8.06% | -21.92% | -40.00% | 151.90 M USD | ||
| 3767 | UNCY Unicycive Therapeutics, Inc. - Common Stock | 5.27 USD | -4.18% | -6.56% | +0.19% | -19.05% | 146.80 M USD | ||
| 3772 | ADCT ADC Therapeutics SA Common Shares | 1.14 USD | +1.79% | +14.00% | +1.79% | -63.11% | 145.54 M USD |